Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805383 · ClinicalTrials.gov registry record · NA
Randomized Trial of Follow-up to Mailed FIT Kits
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 2,135
- Enrollment target
NCT06805383: Completed NA study, sponsored by University of Southern California.
NCT06805383 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 2,135 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06805383, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,135 participants
- Enrollment target
Study Summary
This study aims to assess whether follow-up calls can increase the return rate of mailed FIT Kits. To assess this, a randomly selected half of eligible patients were randomized to receive a follow-up call reminding the patient to return the FIT Kit.
Primary Outcome
FIT Kit returned to health system for processing.
Interventions
- BEHAVIORAL Phone call
- OTHER Mailed FIT Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,135 participants |
| Start Date | 2024-10-16 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT06805383 record still lists
NCT06805383 is an interventional study that assigns participants to a tested intervention. Its 2,135 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% higher).
The record links to 0 conditions, and to 2 interventions - of which Phone call is the first listed.
NCT06805383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06805383 about?
NCT06805383 is a clinical study titled "Randomized Trial of Follow-up to Mailed FIT Kits". This study aims to assess whether follow-up calls can increase the return rate of mailed FIT Kits. To assess this, a randomly selected half of eligible patients were randomized to receive a follow-up call reminding the patient to return the FIT Kit.
What is the current status of trial NCT06805383?
This trial is currently completed. It is a NA study. The enrollment target is 2,135 participants. The study started on 2024-10-16. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT06805383?
The interventions under investigation include: Phone call (BEHAVIORAL), Mailed FIT Kit (OTHER).
Who is sponsoring clinical trial NCT06805383?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06805383's enrollment target sits among peer trials
2,135 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI